rentradВестник рентгенологии и радиологииJournal of radiology and nuclear medicine0042-46762619-0478Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists10.20862/0042-4676-2021-102-4-255-262rentrad-660Research ArticleОБЗОРЫREVIEWSАктуальные вопросы рационального применения йодсодержащих контрастных средств в лучевой диагностикеTopical Issues of Rational Use of Iodine-Containing Contrast Agents in X-Ray Diagnosticshttps://orcid.org/0000-0001-8887-4420ШимановскийН. Л.ShimanovskiyN. L.

Шимановский Николай Львович, д. м. н., профессор, чл.-корр. РАН, заведующий кафедрой молекулярной фармакологии и радиобиологии им. академика П.В. Сергеева

ул. Островитянова, 1, Москва, 117997 

Nikolay L. Shimanovskiy, Dr. Med. Sc., Professor, Corresponding Member of RAS, Chief of Chair of Molecular Pharmacology and Radiobiology 

ul. Ostrovityanova, 1, Moscow, 117997 

shimannn@yandex.ruФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииРоссияPirogov Russian National Research Medical UniversityRussian Federation2021150920211024255262Copyright © Шимановский Н.Л., 20212021Шимановский Н.Л.Shimanovskiy N.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.russianradiology.ru/jour/article/view/660

Рассмотрены возможности рационального применения йодированных рентгеноконтрастных средств при компьютерной томографии и чрескожных коронарных вмешательствах с учетом пути, способа их введения и вязкости растворов. При фиксировании скорости введения йода и температуры вводимого раствора необходимое давление введения рентгеноконтрастных средств определяется вязкостью раствора.

The possibilities of rational use of iodine radiopaque agents in computed tomography and percutaneous coronary interventions are considered, taking into account the route, method of their administration and the viscosity of their solutions. When fixing the rate of iodine administration and the temperature of the injected solution, the required injection pressure of the contrast media is determined by the solution viscosity.

йодированные рентгеноконтрастные средствакомпьютерная томографияйопромидобзорiodine radiopaque agentscomputed tomographyiopromidereviewReferencesSchöckel L, Jost G, Seidensticker P, et al. Developments in X-Ray contrast media and the potential impact on computed tomography. Invest Radiol. 2020; 55(9): 592–7. https://doi.org/10.1097/RLI.0000000000000696.Schöckel L, Jost G, Seidensticker P, et al. Developments in X-Ray contrast media and the potential impact on computed tomography. Invest Radiol. 2020; 55(9): 592–7. https://doi.org/10.1097/RLI.0000000000000696.Ojeda S, Romaguera R, Cruz-González I, Moreno R. Spanish Cardiac Catheterization and Coronary Intervention Registry. 29th Official Report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990–2019). Rev Esp Cardiol (Engl Ed). 2020; 73(11): 927–36. https://doi.org/10.1016/j.rec.2020.09.005.Ojeda S, Romaguera R, Cruz-González I, Moreno R. Spanish Cardiac Catheterization and Coronary Intervention Registry. 29th Official Report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990–2019). Rev Esp Cardiol (Engl Ed). 2020; 73(11): 927–36. https://doi.org/10.1016/j.rec.2020.09.005.ESUR Guidelines on contrast agents. European Society of Urogenital Radiology. Available at: http://www.esur.org/fileadmin/content/2019/ESUR_ Guidelines_10.0_Final_Version.pdf (accessed June 17, 2021).ESUR Guidelines on contrast agents. European Society of Urogenital Radiology. Available at: http://www.esur.org/fileadmin/content/2019/ESUR_ Guidelines_10.0_Final_Version.pdf (accessed June 17, 2021).Suh YJ, Yoon SH, Hong H, et al. Acute adverse reactions to nonionic iodinated contrast media: a meta-analysis. Invest Radiol. 2019; 54(9): 589–99. https://doi.org/10.1097/RLI.0000000000000568.Suh YJ, Yoon SH, Hong H, et al. Acute adverse reactions to nonionic iodinated contrast media: a meta-analysis. Invest Radiol. 2019; 54(9): 589–99. https://doi.org/10.1097/RLI.0000000000000568.Чучалин А.Г., Яснецов В.В. (ред.) Федеральное руководство по использованию лекарственных средств (формулярная система). Вып. 17. М.; 2016: 942–6. [Chuchalin АG, Yasnetsov VV (Eds) Federal guidelines for the use of drugs (formulary system). Issue 17. Мoscow; 2016: 942–6 (in Russ.).]Чучалин А.Г., Яснецов В.В. (ред.) Федеральное руководство по использованию лекарственных средств (формулярная система). Вып. 17. М.; 2016: 942–6. [Chuchalin АG, Yasnetsov VV (Eds) Federal guidelines for the use of drugs (formulary system). Issue 17. Мoscow; 2016: 942–6 (in Russ.).]Palkowitsch PK, Bostelmann S, Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol. 2014; 55(6): 707–14. https://doi.org/10.1177/0284185113504753.Palkowitsch PK, Bostelmann S, Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol. 2014; 55(6): 707–14. https://doi.org/10.1177/0284185113504753.Chen JY, Liu Y, Zhou YL, et al. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: realworld multicenter experience with 17,513 patients from the TRUST trial. Int J Cardiovasc Imaging. 2015; 31(7): 1281–91. https://doi.org/10.1007/s10554-015-0688-9.Chen JY, Liu Y, Zhou YL, et al. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: realworld multicenter experience with 17,513 patients from the TRUST trial. Int J Cardiovasc Imaging. 2015; 31(7): 1281–91. https://doi.org/10.1007/s10554-015-0688-9.Rengo M, Dharampal A, Lubbers M, et al. Impact of iodine concentration and iodine delivery rate on contrast enhancement in coronary CT angiography: a randomized multicenter trial (CT-CON). Eur Radiol. 2019; 29(11): 6109–18. https://doi.org/10.1007/s00330-019-06196-7.Rengo M, Dharampal A, Lubbers M, et al. Impact of iodine concentration and iodine delivery rate on contrast enhancement in coronary CT angiography: a randomized multicenter trial (CT-CON). Eur Radiol. 2019; 29(11): 6109–18. https://doi.org/10.1007/s00330-019-06196-7.García M, Aguirre U, Martinez A, et al. Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department. Br J Radiol. 2014; 87(1033): 20130511. https://doi.org/10.1259/bjr.20130511.García M, Aguirre U, Martinez A, et al. Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department. Br J Radiol. 2014; 87(1033): 20130511. https://doi.org/10.1259/bjr.20130511.Kok M, Mihl C, Hendriks BM, et al. Patient comfort during contrast media injection in coronary computed tomographic angiography using varying contrast media concentrations and flow rates: results from the EICAR Trial. Invest Radiol. 2016; 51(12): 810–15. https://doi.org/10.1097/RLI.0000000000000284.Kok M, Mihl C, Hendriks BM, et al. Patient comfort during contrast media injection in coronary computed tomographic angiography using varying contrast media concentrations and flow rates: results from the EICAR Trial. Invest Radiol. 2016; 51(12): 810–15. https://doi.org/10.1097/RLI.0000000000000284.Halsell RD. Heating contrast media: role in contemporary angiography. Radiology. 1987; 164: 276–8. https://doi.org/10.1148/radiology.164.1.3588919.Halsell RD. Heating contrast media: role in contemporary angiography. Radiology. 1987; 164: 276–8. https://doi.org/10.1148/radiology.164.1.3588919.Chaya A, Jost G, Endrikat J. Piston-based vs peristaltic pumpbased ct injector systems. Radiol Technol. 2019; 90(4): 344–52.Chaya A, Jost G, Endrikat J. Piston-based vs peristaltic pumpbased ct injector systems. Radiol Technol. 2019; 90(4): 344–52.Wildberger JE, Mahnken AH, Seidensticker PR. Aorto-peripheral MDCT angiography: implications for contrast medium delivery. Imaging Decisions. 2007; 4: 8–12. https://doi.org/10.1111/j.1617-0830.2007.00109.x.Wildberger JE, Mahnken AH, Seidensticker PR. Aorto-peripheral MDCT angiography: implications for contrast medium delivery. Imaging Decisions. 2007; 4: 8–12. https://doi.org/10.1111/j.1617-0830.2007.00109.x.ACR Manual on Contrast Media 2021. ACR Committee on Drugs and Contrast Media. Available at: https://www.acr.org/-/media/ACR/files/clinical-resources/ contrast_media.pdf (accessed June 17, 2021).ACR Manual on Contrast Media 2021. ACR Committee on Drugs and Contrast Media. Available at: https://www.acr.org/-/media/ACR/files/clinical-resources/ contrast_media.pdf (accessed June 17, 2021).Hendriks BM, Kok M, Mihl C, et al. Individually tailored contrast enhancement in CT pulmonary angiography. Br J Radiol. 2016; 89: 20150850. https://doi.org/10.1259/bjr.20150850.Hendriks BM, Kok M, Mihl C, et al. Individually tailored contrast enhancement in CT pulmonary angiography. Br J Radiol. 2016; 89: 20150850. https://doi.org/10.1259/bjr.20150850.Endrikat J, Michel A, Kölbach R, et al. Risk of hypersensitivity reactions to iopromide after intra-arterial versus intravenous administration: a nested case-control analysis of 133,331 patients. Invest Radiol. 2020; 55(1): 38–44. https://doi.org/10.1097/RLI.0000000000000611.Endrikat J, Michel A, Kölbach R, et al. Risk of hypersensitivity reactions to iopromide after intra-arterial versus intravenous administration: a nested case-control analysis of 133,331 patients. Invest Radiol. 2020; 55(1): 38–44. https://doi.org/10.1097/RLI.0000000000000611.Cha MJ, Kang DY, Lee W, et al. Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients. Radiology. 2019; 293(1): 117–24. https://doi.org/10.1148/radiol.2019190485.Cha MJ, Kang DY, Lee W, et al. Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients. Radiology. 2019; 293(1): 117–24. https://doi.org/10.1148/radiol.2019190485.Zhang B, Liu J, Dong Y, et al. Extrinsic warming of lowosmolality iodinated contrast media to 37 °C reduced the rate of allergic-like reaction. Allergy Asthma Proc. 2018; 39(6): e55–63. https://doi.org/10.2500/aap.2018.39.4160.Zhang B, Liu J, Dong Y, et al. Extrinsic warming of lowosmolality iodinated contrast media to 37 °C reduced the rate of allergic-like reaction. Allergy Asthma Proc. 2018; 39(6): e55–63. https://doi.org/10.2500/aap.2018.39.4160.Sodagari F, Mozaffary A, Wood CG 3rd, et al. Reactions to both nonionic iodinated and gadolinium-based contrast media: incidence and clinical characteristics. AJR Am J Roentgenol. 2018; 210(4): 715–9. https://doi.org/10.2214/AJR.17.18655.Sodagari F, Mozaffary A, Wood CG 3rd, et al. Reactions to both nonionic iodinated and gadolinium-based contrast media: incidence and clinical characteristics. AJR Am J Roentgenol. 2018; 210(4): 715–9. https://doi.org/10.2214/AJR.17.18655.Kim SR, Lee JH, Park KH, et al. Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography. Clin Exp Allergy. 2017; 47(1): 106–12. https://doi.org/10.1111/cea.12803.Kim SR, Lee JH, Park KH, et al. Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography. Clin Exp Allergy. 2017; 47(1): 106–12. https://doi.org/10.1111/cea.12803.Dillman JR, Strouse PJ, Ellis JH, et al. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol. 2007; 188(6): 1643–7. https://doi.org/10.2214/AJR.06.1328.Dillman JR, Strouse PJ, Ellis JH, et al. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol. 2007; 188(6): 1643–7. https://doi.org/10.2214/AJR.06.1328.Kopp AF, Mortele KJ, Cho YD, et al. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008; 49(8): 902–11. https://doi.org/10.1080/02841850802282811.Kopp AF, Mortele KJ, Cho YD, et al. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008; 49(8): 902–11. https://doi.org/10.1080/02841850802282811.Schild H. CM, to see or not to see. Schering Diagnositics, Bayer. 1994. Last update 2018. Available at: https://www.librarything.com/work/10548853 (accessed June 17, 2021).Schild H. CM, to see or not to see. Schering Diagnositics, Bayer. 1994. Last update 2018. Available at: https://www.librarything.com/work/10548853 (accessed June 17, 2021).Guéant-Rodriguez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des. 2006; 12(26): 3359–72. https://doi.org/10.2174/138161206778193999.Guéant-Rodriguez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des. 2006; 12(26): 3359–72. https://doi.org/10.2174/138161206778193999.From AM, Al Badarin FJ, McDonald FS, et al. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv. 2010; 3(4): 351–8. https://doi.org/10.1161/CIRCINTERVENTIONS.109.917070.From AM, Al Badarin FJ, McDonald FS, et al. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv. 2010; 3(4): 351–8. https://doi.org/10.1161/CIRCINTERVENTIONS.109.917070.Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrastinduced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017; 389(10076): 1312–22. https://doi.org/10.1016/S0140-6736(17)30057-0.Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrastinduced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017; 389(10076): 1312–22. https://doi.org/10.1016/S0140-6736(17)30057-0.Nijssen EC, Nelemans PJ, Rennenberg RJ, et al. prophylactic intravenous hydration to protect renal function from intravascular iodinated contrast material (AMACING): longterm results of a prospective, randomised, controlled trial. EClinicalMedicine. 2018; 4–5: 109–16. https://doi.org/10.1016/j.eclinm.2018.10.007.Nijssen EC, Nelemans PJ, Rennenberg RJ, et al. prophylactic intravenous hydration to protect renal function from intravascular iodinated contrast material (AMACING): longterm results of a prospective, randomised, controlled trial. EClinicalMedicine. 2018; 4–5: 109–16. https://doi.org/10.1016/j.eclinm.2018.10.007.

The authors declare that there are no conflicts of interest present.